ACE2 and COVID-19: For example, physiological abnormalities in patients with NAFLD such as impaired glucose and lipid metabolism, platelet hyperactivation and hypercoagulable state 23, the underlying liver fibrosis 24, up-regulated ACE2 25, and a pronounced inflammatory response 26 probably all contribute to severe COVID-19.